Neural Therapeutics to list on Canadian Stock Exchange after raising C$518,000 | How to order Skittles Moonrock online

Learn where to order CBD Oil online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

Toronto-based Neural Therapeutics (CSE: NURL) announced on Thursday a twofold milestone, with both the completion of a C$518,500 capital raise and the receipt of formal permission from the Canadian Securities Exchange to begin listing its shares for trading, another sign that the international psychedelics industry is making slow but steady progress.

The news is a significant step forward for the ethnobotanical drug discovery company, which is developing new therapies such as “sub-hallucinogenic doses of mescaline” to treat drug disorders such as alcohol and opioid dependence.

In a press release, the company said it raised the half million on March 7 from the issuance of just over 17.2 million shares of Neural stock at C$0.03 per share.

While the CSE has formally given Neural Therapeutics permission to list, its shares have not yet begun trading. The launch is “expected to occur shortly,” the company said, and it promised another company update when the exchange chooses a date for trading to commence.

“As Neural enters this exciting phase of development we believe that the visibility in the public markets will be the cornerstone of our long-term value creation strategy,” Neural Therapeutics CEO Ian Campbell said in the release.